A Study of Oncobax®-AK in Patients With Advanced Solid Tumors
Phase 2
Recruiting
- Conditions
- Carcinoma, Renal CellCarcinoma, Non-Small-Cell Lung
- Interventions
- Other: Live Bacterial Product - Akkermansia muciniphila
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- EverImmune
- Target Recruit Count
- 122
- Registration Number
- NCT05865730
- Locations
- 🇧🇪
CHU Ambroise Paré, Mons, Belgium
🇫🇷Centre Georges Francois Leclerc, Dijon, France
🇫🇷Institut Gustave Roussy, Paris, France